arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2005.06541q-bio.CB
收藏

COVID-19患者临床结局的免疫学决定因素:一个定量的观点

Immunological determinants of clinical outcomes in COVID-19: A quantitative perspective

Elizabeth Krieger, Nicole Vissichelli, Stefan Leichtle, Markos Kashioris, Roy Sabo, Don Brophy, Xiang-Yang Wang, Pamela Kimbal, Michael Neale, Myrna G. Serrano,… 展开作者

Elizabeth Krieger, Nicole Vissichelli, Stefan Leichtle, Markos Kashioris, Roy Sabo, Don Brophy, Xiang-Yang Wang, Pamela Kimbal, Michael Neale, Myrna G. Serrano, Gregory A. Buck, Catherine Roberts, Rehan Qayyum, Daniel Nixon, Steven Grossman, Amir A. Toor

摘要:

严重急性呼吸道综合征冠状病毒2型(SARS-CoV-2)具有多种临床表现,从无症状到伴有细胞因子风暴的严重疾病。全球的死亡率也各不相同,从0.5%到13%不等。这种变化可能是由于病原体和宿主因素。宿主因素可能包括免疫应答基因的遗传差异以及HLA和KIR同种异型的变异。为了更好地了解这些免疫反应基因中的遗传变异可能对SARS-CoV-2免疫反应中观察到的差异产生的影响,考虑了病毒生长的幅度以及随后实现感染控制所需的先天和适应性反应的动力系统模型的定量分析。基于这一广泛的定量框架,可以假设COVID 19的症状性到严重症状性表现的范围代表了先天性和适应性免疫应答之间的平衡。在无症状的患者中,迅速和充分的适应性免疫应答可消除感染,而在那些症状严重的患者中,较慢的适应性应答不足会导致正在进行的病毒复制引发失控的细胞因子级联反应。先天性和适应性免疫应答的各种组分中的多态性可引起改变的免疫应答动力学,这将导致疾病的不同严重程度。了解这种遗传变异如何改变对SARS-CoV-2感染的反应对于开发成功的治疗策略至关重要。

英文摘要:

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has a variable clinical presentation that ranges from asymptomatic, to severe disease with cytokine storm. The mortality rates also differ across the globe, ranging from 0.5-13%. This variation is likely due to both pathogen and host factors. Host factors may include genetic differences in the immune response genes as well as variation in HLA and KIR allotypes. To better understand what impact these genetic variants in immune response genes may have in the differences observed in the immune response to SARS-CoV-2, a quantitative analysis of a dynamical systems model that considers both, the magnitude of viral growth, and the subsequent innate and adaptive response required to achieve control of infection is considered. Based on this broad quantitative framework it may be posited that the spectrum of symptomatic to severely symptomatic presentations of COVID19 represents the balance between innate and adaptive immune responses. In asymptomatic patients, prompt and adequate adaptive immune response quells infection, whereas in those with severe symptoms a slower inadequate adaptive response leads to a runaway cytokine cascade fueled by ongoing viral replication. Polymorphisms in the various components of the innate and adaptive immune response may cause altered immune response kinetics that would result in variable severity of illness. Understanding how this genetic variation may alter the response to SARS-CoV-2 infection is critical to develop successful treatment strategies.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑